Website News and Research

RSS

CSL Behring selects BioRx as an approved Berinert provider

BioRx, a specialty pharmacy company, has been named one of a small number of approved providers of Berinert®. Berinert® is a plasma-derived concentrate of C1 esterase inhibitor (human) indicated for the treatment of acute abdominal or facial attacks of hereditary angioedema (HAE) in adult and adolescent patients. CSL Behring, the manufacturer of Berinert® selected BioRx as part of their distribution network to launch this exciting new product in the United States.

8 Dec 2009

Seattle-based Qualis Health selects Genuine Interactive as its interactive agency of record

Qualis Health names Genuine Interactive as its interactive agency of record, according to John Grayson, president of the interactive marketing agency (http://www.genuineinteractive.com). The Seattle-based Qualis Health chose Genuine Interactive after a national review of firms.

8 Dec 2009

Pixantrone demonstrates substantial reduction in cardiac cell toxicity compared to anthracyclines

Cell Therapeutics, Inc. announced today an abstract to be published online at the journal Blood website by M. Hacker, et al. demonstrating significant reduction in cardiac cell toxicity with pixantrone compared to currently marketed anthracyclines. The authors conclude that the reduction is due to pixantrone's inability to generate toxic drug iron complexes and reduced propensity to generate oxygen free radicals.

8 Dec 2009

Workforce Alliance receives $134,790 grant to fund workforce training program

Workforce Alliance was awarded a $134,790 grant by the State of Florida to fund a workforce training program aimed at meeting the high need for skilled health care workers in Palm Beach County.

8 Dec 2009

La Jolla Pharmaceutical enters into definitive merger agreement with Adamis Pharmaceuticals

La Jolla Pharmaceutical Company (“La Jolla”) today announced that it entered into a definitive merger agreement with Adamis Pharmaceuticals Corporation (“Adamis”) on December 4, 2009.

8 Dec 2009

SU2C awards $9.68 million to support high-risk cancer research

Stand Up To Cancer (SU2C) announced today that it is awarding $9.68 million to support high-risk/high-reward cancer research conducted by 13 young scientists.

7 Dec 2009

New analyses of data from Allos Therapeutics’ pivotal PROPEL trial of FOLOTYN reported

Allos Therapeutics, Inc. today reported new analyses of data from the Company’s pivotal PROPEL trial of FOLOTYN™ (pralatrexate injection) in patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).

7 Dec 2009

OrthoAccel Technologies announces the availability of new Continuing Education course

OrthoAccel Technologies, Inc., developers of the AcceleDent System, which is an acceleration device to enhance orthodontics, announced the availability of a new Continuing Education course published by PennWell Corporation, a leader in professional education for many industries, including medicine and dentistry.

5 Dec 2009

First lifestyle magazine and website for nurses launched

Scrubs Magazine (scrubsmag.com), the first lifestyle magazine and website for nurses, premiered November 15. The magazine has paid circulation of 350,000 and will be sold in more than 1,500 nursing apparel stores nationwide. Strategic

5 Dec 2009

JRC's milk chocolate testing methods adopted as international standards

Eighteen EU countries were among the world's top 26 chocolate confectioneries consumers in 2007, ranking from 11.85 kg eaten per capita in Ireland, to 4.5 kg in France and 1.04 kg in Poland. The EU 27 consumed in total 2.5 million tons of chocolate products that year, which account for around half of the global consumption world-wide.

5 Dec 2009

Medithrive wins Patient's Choice Award

Medithrive, Inc. has won the Patient's Choice Award as the favorite dispensary in the SF Bay Area by popular vote conducted by the online website, www.weedmaps.com. Despite only three months in operation, the SF Bay community has selected Medithrive as the preeminent location for accessing medicinal marijuana.

5 Dec 2009

Number of new active TB cases increases from 2007 to 2008, WHO says

The WHO's Stop TB Department released data on Thursday at the 40th Union World Conference on Lung Health indicating that the number of new active TB cases worldwide rose from 9.27 million in 2007 to 9.4 million in 2008, Reuters reports. Experts, who were gathered for the conference in Cancun, Mexico, "called for more research funding to develop better diagnostic tests, vaccines and drugs for tuberculosis, which killed 1.8 million people around the world last year," according to the news service.

4 Dec 2009

Pre-clinical study data of Stemline Therapeutics' IL-3R targeting agents to be presented at the ASH meeting

Stemline Therapeutics, Inc. today announced that data from pre-clinical studies of its IL-3R targeting agents, SL-401 and SL-501, in both in vitro and animal models of human chronic myeloid leukemia (CML) have been selected for poster presentation at the upcoming 51st Annual Meeting of the American Society of Hematology (ASH), to be held in New Orleans from December 5-8, 2009.

4 Dec 2009

Public Campaign Action Fund names Sen. Richard Burr as its final 'Insurance Puppet'

Public Campaign Action Fund, a national campaign finance watchdog group, named Sen. Richard Burr (R-N.C.) its final "Insurance Puppet" in an online advertising campaign targeting North Carolina and Washington, D.C.

4 Dec 2009

Cancer patient “Statement of Principles” brought to the 2009 ASH meeting

A coalition of cancer patient advocacy organizations led by the International Myeloma Foundation (IMF) and the MDS Foundation (MDSF), will bring its cancer patient “Statement of Principles” to the 2009 Meeting of the American Society of Hematology (ASH) in New Orleans December 5th through 8th.

4 Dec 2009

InVivo Therapeutics files an Investigational Device Exemption application with the FDA

InVivo Therapeutics Corporation has filed an Investigational Device Exemption application with the Food and Drug Administration requesting permission to advance to human clinical studies. InVivo is currently conducting its third primate study and expects to receive approval to begin a human study in 2010.

4 Dec 2009

Advantages of Helicos BioSciences' single molecule sequencing technology presented

Helicos BioSciences Corporation announced today that, as previously disclosed, it has posted a presentation on its website regarding the advantages of Helicos’ single molecule sequencing technology in clinical diagnostics.

4 Dec 2009

General Mills' new website provides information on gluten-free products

General Mills has created liveglutenfreely.com to provide consumers with information on gluten-free products and gluten-free recipes. The site lists General Mills products labeled gluten-free and features kitchen-tested recipes for preparing an array of gluten-free foods.

4 Dec 2009

American Pain Society supports FDA drug disposal guidelines

Calling it "an important first step in attempting to reverse an escalating public health menace caused by diversion of prescription opioid pain medications," the American Pain Society today announced its support for a new FDA initiative to encourage consumers to remove unused pain drugs from home medicine cabinets.

3 Dec 2009

Sodexo launches 'Better Tomorrow Plan' to meet the challenges of community and environmental practices

Sodexo (PARIS:SW) (OTCBB:SDXAY), world leader in Quality of Life solutions, announced today the creation of the "Better Tomorrow Plan," designed to better respond to the challenges of proper Nutrition, Health and Wellness, Local communities and Environment.

3 Dec 2009

Website News and Research

CSL Behring selects BioRx as an approved Berinert provider

Seattle-based Qualis Health selects Genuine Interactive as its interactive agency of record

Pixantrone demonstrates substantial reduction in cardiac cell toxicity compared to anthracyclines

Workforce Alliance receives $134,790 grant to fund workforce training program

La Jolla Pharmaceutical enters into definitive merger agreement with Adamis Pharmaceuticals

SU2C awards $9.68 million to support high-risk cancer research

New analyses of data from Allos Therapeutics’ pivotal PROPEL trial of FOLOTYN reported

OrthoAccel Technologies announces the availability of new Continuing Education course

First lifestyle magazine and website for nurses launched

JRC's milk chocolate testing methods adopted as international standards

Medithrive wins Patient's Choice Award

Number of new active TB cases increases from 2007 to 2008, WHO says

Pre-clinical study data of Stemline Therapeutics' IL-3R targeting agents to be presented at the ASH meeting

Public Campaign Action Fund names Sen. Richard Burr as its final 'Insurance Puppet'

Cancer patient “Statement of Principles” brought to the 2009 ASH meeting

InVivo Therapeutics files an Investigational Device Exemption application with the FDA

Advantages of Helicos BioSciences' single molecule sequencing technology presented

General Mills' new website provides information on gluten-free products

American Pain Society supports FDA drug disposal guidelines

Sodexo launches 'Better Tomorrow Plan' to meet the challenges of community and environmental practices

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News